Multiple single nucleotide polymorphisms of the transient receptor potential vanilloid 1 (TRPV1) genes associate with cough sensitivity to capsaicin in healthy subjects.


Journal

Pulmonary pharmacology & therapeutics
ISSN: 1522-9629
Titre abrégé: Pulm Pharmacol Ther
Pays: England
ID NLM: 9715279

Informations de publication

Date de publication:
04 2020
Historique:
received: 04 09 2019
revised: 10 01 2020
accepted: 10 01 2020
pubmed: 15 1 2020
medline: 7 4 2021
entrez: 15 1 2020
Statut: ppublish

Résumé

Cough is a common symptom in several respiratory diseases and may occur in healthy subjects as a defense mechanism against noxious inhalants. Cough response is mediated by transient receptor potential vanilloid-1 (TRPV1) expressed by C-fibers in the airways. Capsaicin (CPS) activates TRPV1 and is regularly used as a tool to study cough response. Although single nucleotide polymorphisms (SNPs) of TRPV1 are implicated in CPS binding, their role in cough response is not fully elucidated. In this study we investigated the relationship between capsaicin cough challenge sensitivity and multiple TRPV1 polymorphisms. The dose-response of cough induced by CPS inhalation was determined in 20 unselected healthy volunteers and the concentration of CPS causing two coughs (C2) was calculated. The SNPs I585V(rs8065080), T505A(rs17633288), T469I(rs224534), I315 M(rs222747), P91S(rs222749), and K2N(rs9894618) were characterized in blood DNA from each subject. The association between combinations of TRPV1 SNPs and CPS sensitivity of each subject was assessed by linear regression. All subjects were wild type for T505A and K2N, while they exhibited two to six SNPs with high capsaicin responsiveness. The major contribution to CPS sensitivity in vivo (C2) was due to four combined SNPs: 315 M, 585I, 469I and 91S (p = 0.015). We found, however, that the presence of a minimum of two polymorphisms, such as 91S combined with 315 M (p = 0.032) or 91S with 585I (p = 0.025), was sufficient to detect an effect on C2. Capsaicin cough challenge sensitivity in healthy subjects is dependent on multiple TRPV1 polymorphisms.

Sections du résumé

BACKGROUND
Cough is a common symptom in several respiratory diseases and may occur in healthy subjects as a defense mechanism against noxious inhalants. Cough response is mediated by transient receptor potential vanilloid-1 (TRPV1) expressed by C-fibers in the airways. Capsaicin (CPS) activates TRPV1 and is regularly used as a tool to study cough response. Although single nucleotide polymorphisms (SNPs) of TRPV1 are implicated in CPS binding, their role in cough response is not fully elucidated.
AIMS
In this study we investigated the relationship between capsaicin cough challenge sensitivity and multiple TRPV1 polymorphisms.
METHODS
The dose-response of cough induced by CPS inhalation was determined in 20 unselected healthy volunteers and the concentration of CPS causing two coughs (C2) was calculated. The SNPs I585V(rs8065080), T505A(rs17633288), T469I(rs224534), I315 M(rs222747), P91S(rs222749), and K2N(rs9894618) were characterized in blood DNA from each subject. The association between combinations of TRPV1 SNPs and CPS sensitivity of each subject was assessed by linear regression.
RESULTS
All subjects were wild type for T505A and K2N, while they exhibited two to six SNPs with high capsaicin responsiveness. The major contribution to CPS sensitivity in vivo (C2) was due to four combined SNPs: 315 M, 585I, 469I and 91S (p = 0.015). We found, however, that the presence of a minimum of two polymorphisms, such as 91S combined with 315 M (p = 0.032) or 91S with 585I (p = 0.025), was sufficient to detect an effect on C2.
CONCLUSION
Capsaicin cough challenge sensitivity in healthy subjects is dependent on multiple TRPV1 polymorphisms.

Identifiants

pubmed: 31935455
pii: S1094-5539(19)30213-5
doi: 10.1016/j.pupt.2020.101889
pii:
doi:

Substances chimiques

TRPV Cation Channels 0
TRPV1 receptor 0
Capsaicin S07O44R1ZM

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

101889

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no conflict of interest related to this paper.

Auteurs

Filippo Liviero (F)

Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Italy.

Manuela Campisi (M)

Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Italy.

Maria C Scarpa (MC)

Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Italy.

Paola Mason (P)

Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Italy.

Gabriella Guarnieri (G)

Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Italy.

Piero Maestrelli (P)

Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Italy. Electronic address: piero.maestrelli@unipd.it.

Sofia Pavanello (S)

Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH